VisnegarwalaFKrauseKLMusherDM. Severe diabetes associated with protease inhibitor therapy (letter). Ann Intern Med1997;127:947.
3.
EastoneJADeckerCF. New-onset diabetes mellitus associated with use of protease inhibitor (letter). Ann Intern Med1997;127:948.
4.
FosterDW. Diabetes mellitus. In: FauciASBraunwaldEIsselbacherKJWilsonJDMartinJBKasperDL, eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998:2060–80.
5.
JonesJK. Adverse drug reactions in the community health setting: Approaches to recognising, counseling and reporting. Fam Commun Health1982;5:58–67.
6.
GargAGrundySM. Nicotinic acid as therapy for dyslipidemia in non-insulin dependent diabetes mellitus. JAMA1990;264:723–6.
7.
Jonville-BeraAPZakianABeraFJCarréPAutretE. Possible pravastatin and diuretic-induced diabetes mellitus (letter). Ann Pharmacother1994;28:964–5.
8.
BertholonMMayerAFrancinaAThivoletCH. Interference of dapsone in HbA1c monitoring of a type 1 diabetic patient with necrobiosis lipoidica (letter). Diabetes Care1994;17:1364.
9.
Protease inhibitors may increase blood glucose in HIV patients. FDA Med Bull1997;27(2):3.
